Cardio Catch-Up: Medtech Innovation Takes Center Stage At TCT 2022

 
• By Reed Miller

This edition of Medtech Insight’s regular round-up of heart-tech news covers some highlights of this years’ Transcatheter Cardiovascular Therapeutics (TCT) meeting in September, including the latest trials of Abbott's Amulet left-atrial appendage closure device and Medtronic's Intrepid transcatheter mitral valve replacement.

View of the Boston Harbor in Boston, Massachusetts, USA with its mix of modern and historic architecture in a cross processed image.
• Source: Shutterstock

More from Cardiology

More from Device Area